|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,131,983 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,070,832 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 25 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-04-07 |
4 |
OE |
$26.49 |
$26,490 |
D/D |
1,000 |
298,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-04-09 |
4 |
AS |
$79.06 |
$790,600 |
D/D |
(10,000) |
298,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-04-27 |
4 |
AS |
$97.73 |
$1,954,600 |
D/D |
(20,000) |
298,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-04-28 |
4 |
AS |
$97.58 |
$1,951,600 |
D/D |
(20,000) |
298,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-04-30 |
4 |
A |
$62.59 |
$21,217 |
D/D |
339 |
298,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-05-01 |
4 |
AS |
$89.38 |
$357,520 |
D/D |
(4,000) |
298,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-05-04 |
4 |
AS |
$88.00 |
$440,000 |
D/D |
(5,000) |
298,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-05-08 |
4 |
AS |
$91.72 |
$1,834,400 |
D/D |
(20,000) |
298,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-04-20 |
4 |
OE |
$38.59 |
$385,900 |
D/D |
10,000 |
300,031 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-04-23 |
4 |
OE |
$38.59 |
$385,900 |
D/D |
10,000 |
300,031 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-04-24 |
4 |
OE |
$38.59 |
$385,900 |
D/D |
10,000 |
300,031 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-15 |
4 |
D |
$94.53 |
$2,660,358 |
D/D |
(28,143) |
300,558 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-03-22 |
4 |
D |
$78.52 |
$433,352 |
D/D |
(5,519) |
302,498 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-04-22 |
4 |
AS |
$78.91 |
$789,100 |
D/D |
(10,000) |
302,498 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-04-23 |
4 |
AS |
$79.34 |
$793,400 |
D/D |
(10,000) |
302,498 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-05-01 |
4 |
OE |
$21.51 |
$86,040 |
D/D |
4,000 |
302,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-02-18 |
4 |
OE |
$26.49 |
$185,430 |
D/D |
7,000 |
302,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-02-19 |
4 |
OE |
$26.49 |
$185,430 |
D/D |
7,000 |
302,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-03-11 |
4 |
OE |
$26.49 |
$185,430 |
D/D |
7,000 |
302,652 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-03-12 |
4 |
OE |
$26.49 |
$185,430 |
D/D |
7,000 |
302,652 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-04-30 |
4 |
OE |
$37.46 |
$37,460 |
D/D |
1,000 |
303,498 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-05-04 |
4 |
OE |
$21.51 |
$107,550 |
D/D |
5,000 |
303,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-02-17 |
4 |
OE |
$26.49 |
$211,920 |
D/D |
8,000 |
303,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-12-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
700 |
303,689 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-12-15 |
4 |
AS |
$82.71 |
$496,260 |
D/D |
(6,000) |
303,689 |
0 |
- |
|
850 Records found
|
|
Page 25 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|